Cilnidipine is a fourth-generation, once-daily dihydropyridine calcium channel blocker (CCB) used to treat hypertension by blocking both L-type and N-type calcium channels. It effectively lowers blood pressure (systolic and diastolic) while reducing sympathetic nerve activity, which minimizes reflex tachycardia. Common side effects include flushing, dizziness, and ankle swelling.